Japan · Delayed Price · Currency is JPY CellSource Statistics
Total Valuation
CellSource has a market cap or net worth of JPY 7.87 billion. The enterprise value is 3.22 billion.
| Market Cap | 7.87B |
| Enterprise Value | 3.22B |
Important Dates
The next estimated earnings date is Wednesday, March 11, 2026.
| Earnings Date | Mar 11, 2026 |
| Ex-Dividend Date | Oct 30, 2025 |
Share Statistics
CellSource has 19.83 million shares outstanding. The number of shares has increased by 2.88% in one year.
| Current Share Class | 19.83M |
| Shares Outstanding | 19.83M |
| Shares Change (YoY) | +2.88% |
| Shares Change (QoQ) | +0.00% |
| Owned by Insiders (%) | 44.31% |
| Owned by Institutions (%) | 3.93% |
| Float | 8.79M |
Valuation Ratios
The trailing PE ratio is 787.12.
| PE Ratio | 787.12 |
| Forward PE | n/a |
| PS Ratio | 2.12 |
| PB Ratio | 1.31 |
| P/TBV Ratio | 1.32 |
| P/FCF Ratio | 27.14 |
| P/OCF Ratio | 23.64 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.37, with an EV/FCF ratio of 11.09.
| EV / Earnings | 321.52 |
| EV / Sales | 0.87 |
| EV / EBITDA | 8.37 |
| EV / EBIT | 19.25 |
| EV / FCF | 11.09 |
Financial Position
The company has a current ratio of 12.41, with a Debt / Equity ratio of 0.01.
| Current Ratio | 12.41 |
| Quick Ratio | 11.41 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.14 |
| Debt / FCF | 0.19 |
| Interest Coverage | 167.00 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 0.96% |
| Return on Capital Employed (ROCE) | 2.54% |
| Weighted Average Cost of Capital (WACC) | 2.43% |
| Revenue Per Employee | 25.07M |
| Profits Per Employee | 67,568 |
| Employee Count | 157 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CellSource has paid 99.00 million in taxes.
| Income Tax | 99.00M |
| Effective Tax Rate | 90.83% |
Stock Price Statistics
The stock price has decreased by -53.40% in the last 52 weeks. The beta is -0.33, so CellSource's price volatility has been lower than the market average.
| Beta (5Y) | -0.33 |
| 52-Week Price Change | -53.40% |
| 50-Day Moving Average | 430.46 |
| 200-Day Moving Average | 576.28 |
| Relative Strength Index (RSI) | 42.01 |
| Average Volume (20 Days) | 73,690 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CellSource had revenue of JPY 3.71 billion and earned 10.00 million in profits. Earnings per share was 0.50.
| Revenue | 3.71B |
| Gross Profit | 2.09B |
| Operating Income | 167.00M |
| Pretax Income | 109.00M |
| Net Income | 10.00M |
| EBITDA | 384.00M |
| EBIT | 167.00M |
| Earnings Per Share (EPS) | 0.50 |
Balance Sheet
The company has 4.71 billion in cash and 55.00 million in debt, with a net cash position of 4.66 billion or 234.84 per share.
| Cash & Cash Equivalents | 4.71B |
| Total Debt | 55.00M |
| Net Cash | 4.66B |
| Net Cash Per Share | 234.84 |
| Equity (Book Value) | 6.02B |
| Book Value Per Share | 303.49 |
| Working Capital | 5.05B |
Cash Flow
In the last 12 months, operating cash flow was 333.00 million and capital expenditures -43.00 million, giving a free cash flow of 290.00 million.
| Operating Cash Flow | 333.00M |
| Capital Expenditures | -43.00M |
| Free Cash Flow | 290.00M |
| FCF Per Share | 14.63 |
Margins
Gross margin is 56.24%, with operating and profit margins of 4.50% and 0.27%.
| Gross Margin | 56.24% |
| Operating Margin | 4.50% |
| Pretax Margin | 2.94% |
| Profit Margin | 0.27% |
| EBITDA Margin | 10.35% |
| EBIT Margin | 4.50% |
| FCF Margin | 7.81% |
Dividends & Yields
This stock pays an annual dividend of 5.00, which amounts to a dividend yield of 1.20%.
| Dividend Per Share | 5.00 |
| Dividend Yield | 1.20% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 980.00% |
| Buyback Yield | -2.88% |
| Shareholder Yield | -1.63% |
| Earnings Yield | 0.13% |
| FCF Yield | 3.68% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on October 28, 2021. It was a forward split with a ratio of 3.
| Last Split Date | Oct 28, 2021 |
| Split Type | Forward |
| Split Ratio | 3 |
Scores
CellSource has an Altman Z-Score of 10.9 and a Piotroski F-Score of 4.
| Altman Z-Score | 10.9 |
| Piotroski F-Score | 4 |